What is Pacira BioSciences Inc (PCRX)?
Pacira BioSciences Inc is a pharmaceutical company specializing in the development and commercialization of non-opioid pain management and regenerative health solutions. The company focuses on products designed to improve patient outcomes and reduce reliance on opioids in pain management. Its portfolio includes injectable products used primarily in hospitals and ambulatory surgery centers. Pacira BioSciences operates in the biotechnology and pharmaceutical sectors, emphasizing innovation in local analgesia and regenerative medicine. The company engages in research and development activities to expand its product offerings and enhance therapeutic options for pain management. Its operations include manufacturing, marketing, and distribution of its proprietary products across various healthcare settings.
Pacira BioSciences Inc Stock Price Today: Live Overview
The price today is shaped by active market trading for Pacira BioSciences Inc, currently at $22.19. Its price has fluctuated between $21.79 and $22.72, registering a daily change of -2.3915%.
FAQ: Pacira BioSciences Inc (PCRX)
What is the current price of PCRX stock?
Pacira BioSciences Inc's current price is $22.19.
Does PCRX pay dividends?
Pacira BioSciences Inc pays dividends.
Does PCRX have a formal corporate presence or regional headquarters in the UAE?
Pacira BioSciences Inc operates via partners and distributors in the UAE without an official regional office or subsidiary.
What is PCRX best known for?
Pacira BioSciences Inc is most famous for its non-opioid pain management products.
What assets are typically shown together with PCRX?
Commonly shown alongside PCRX: SIGA Tech, AstraZeneca - SEK, Gyre Therapeutics Inc
Latest shares articles



